Back to search

2′,5′-Oligoadenylate-Antisense Chimeras Cause RNase L to Selectively Degrade bcr/abl mRNA in Chronic Myelogenous Leukemia Cells

Data up to Jan 2025

Published1998
Citations26
References36

Total Citations Per Year

Abstract

References (36)

Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

1990 • 2,207 citations

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

1994 • 514 citations

Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action

1993 • 509 citations

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]

1994 • 495 citations

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]

1994 • 378 citations

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1990 • 371 citations

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1991 • 353 citations

Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products.

1985 • 266 citations

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.

1992 • 223 citations

Blockage of NF-κB Signaling by Selective Ablation of an mRNA target by 2-5A Antisense Chimeras

1994 • 217 citations

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

1994 • 176 citations

Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.

1994 • 156 citations

Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line

1993 • 141 citations

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.

1993 • 109 citations

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides

1992 • 97 citations

Antisense oligonucleotides as therapeutics for malignant diseases.

1997 • 91 citations

2-5A-Dependent RNase L

1997 • 85 citations

Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides

1992 • 83 citations

Targeting RNA decay with 2′,5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells

1997 • 71 citations

BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase

1998 • 69 citations

BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism [see comments]

1995 • 62 citations

Treatment of Philadelphia1 Leukemia in Severe Combined Immunodeficient Mice by Combination of Cyclophosphamide and bcr/abl Antisense Oligodeoxynucleotides

1997 • 57 citations

Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines

1993 • 56 citations

Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia [see comments]

1994 • 56 citations

Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes.

1995 • 46 citations

Catalytic Cleavage of an RNA Target by 2–5A Antisense and RNase L

1995 • 44 citations

Inhibition of Protein-Tyrosine Kinase Activity in Intact Cells by the Aptameric Action of Oligodeoxynucleotides

1995 • 40 citations

2',5'-Oligoadenylate:antisense chimeras. Synthesis and properties

1993 • 38 citations

(2′‐5′)オリゴアデニル酸‐アンチセンスキメラでの分解のため標的RNA

1993 • 31 citations

Development of 2',5'-Oligonucleotides as Therapeutic Agents

1994 • 27 citations

Synthesis and Characterization of Composite Nucleic Acids Containing 2‵,5‵-Oligoriboadenylate Linked to Antisense DNA

1996 • 23 citations

Synthesis of a 5′-thiophosphate analogue of 2-5A, a phosphatase resistant activator of the 2-5A-dependent ribonuclease

1994 • 23 citations

Synthesis and Properties of Second-Generation 2-5A-Antisense Chimeras with Enhanced Resistance to Exonucleases

1997 • 18 citations

Nuclease-Resistant Composite 2‘,5‘-Oligoadenylate−3‘,5‘-Oligonucleotides for the Targeted Destruction of RNA: 2−5A-Iso-antisense

1998 • 17 citations

Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide

1990 • 17 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
2′,5′-Oligoadenylate-Antisense Chimeras Cause RNase L to Selectively Degrade bcr/abl mRNA… (1998) – Blood | Metascience Observatory Explorer